| CPC A61K 35/28 (2013.01) [A61K 8/981 (2013.01); A61K 8/983 (2013.01); A61K 35/12 (2013.01); A61K 35/16 (2013.01); A61K 35/22 (2013.01); A61Q 19/00 (2013.01); A61Q 19/08 (2013.01); A61K 2800/74 (2013.01); A61K 2800/86 (2013.01)] | 24 Claims |
|
1. A topical composition for treating wounds comprising an aqueous concentrate of a heterogeneous population of purified, intact microvesicles,
wherein the intact microvesicles range in size from 2 nm to 5000 nm,
wherein the intact microvesicles have smooth and uncorrugated borders and appear intact when examined by electron microscopy, and
wherein the intact microvesicles enhance tissue regeneration, promote wound healing, enhance nerve growth, remodel scarred tissue, modulate immune reactions, alter neoplastic cell growth, and/or decrease abscess formation of a tissue when administered to a patient.
|